Name | Number of supported studies | Average coverage | |
---|---|---|---|
respiratory goblet cell | 8 studies | 68% ± 13% | |
ciliated cell | 8 studies | 31% ± 12% | |
mucus secreting cell | 7 studies | 52% ± 27% | |
secretory cell | 6 studies | 45% ± 19% | |
club cell | 5 studies | 54% ± 13% | |
deuterosomal cell | 4 studies | 58% ± 15% | |
duct epithelial cell | 4 studies | 59% ± 13% | |
epithelial cell | 3 studies | 44% ± 17% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 4 studies | 32% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 84% | 6781.16 | 484 / 578 | 60% | 160.20 | 689 / 1155 |
stomach | 70% | 1219.55 | 251 / 359 | 37% | 110.51 | 107 / 286 |
breast | 39% | 39.71 | 178 / 459 | 50% | 54.69 | 554 / 1118 |
esophagus | 14% | 1386.10 | 199 / 1445 | 38% | 108.43 | 70 / 183 |
pancreas | 4% | 4.50 | 12 / 328 | 45% | 26.01 | 80 / 178 |
prostate | 27% | 92.05 | 65 / 245 | 8% | 1.23 | 41 / 502 |
uterus | 2% | 255.47 | 4 / 170 | 26% | 101.00 | 119 / 459 |
bladder | 5% | 3.95 | 1 / 21 | 19% | 25.51 | 97 / 504 |
tonsil | 0% | 0 | 0 / 0 | 16% | 4.53 | 7 / 45 |
intestine | 1% | 17.24 | 5 / 966 | 14% | 51.83 | 74 / 527 |
skin | 0% | 0.67 | 8 / 1809 | 5% | 2.27 | 22 / 472 |
ovary | 1% | 2.56 | 2 / 180 | 3% | 0.66 | 11 / 430 |
liver | 1% | 0.37 | 2 / 226 | 3% | 0.43 | 11 / 406 |
adipose | 3% | 5.82 | 40 / 1204 | 0% | 0 | 0 / 0 |
thymus | 1% | 1.19 | 6 / 653 | 1% | 0.85 | 9 / 605 |
adrenal gland | 2% | 2.86 | 5 / 258 | 0% | 0 | 0 / 230 |
peripheral blood | 1% | 126.77 | 13 / 929 | 0% | 0 | 0 / 0 |
blood vessel | 1% | 1.20 | 11 / 1335 | 0% | 0 | 0 / 0 |
muscle | 1% | 0.71 | 6 / 803 | 0% | 0 | 0 / 0 |
heart | 1% | 0.56 | 5 / 861 | 0% | 0 | 0 / 0 |
spleen | 0% | 0.17 | 1 / 241 | 0% | 0 | 0 / 0 |
kidney | 0% | 0 | 0 / 89 | 0% | 0.08 | 3 / 901 |
brain | 0% | 0.05 | 3 / 2642 | 0% | 0.03 | 1 / 705 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0034144 | Biological process | negative regulation of toll-like receptor 4 signaling pathway |
GO_0002227 | Biological process | innate immune response in mucosa |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005576 | Cellular component | extracellular region |
GO_0008289 | Molecular function | lipid binding |
GO_0003674 | Molecular function | molecular_function |
Gene name | BPIFB1 |
Protein name | BPI fold-containing family B member 1 (Long palate, lung and nasal epithelium carcinoma-associated protein 1) (von Ebner minor salivary gland protein) (VEMSGP) BPI fold containing family B member 1 |
Synonyms | C20orf114 UNQ706/PRO1357 LPLUNC1 |
Description | FUNCTION: May play a role in innate immunity in mouth, nose and lungs. Binds bacterial lipopolysaccharide (LPS) and modulates the cellular responses to LPS. . |
Accessions | A2A2R0 ENST00000423645.5 Q8TDL5 ENST00000253354.2 [Q8TDL5-1] |